Evaluation of endothelial and platelet derived microparticles in patients with acute coronary syndrome

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 12, 2015, Pages OC09-OC13

  George, Melvin ^a   Ganesh, M R ^a   Sridhar, Aruna ^a   Jena, Amrita ^a   Rajaram, Muthukumar ^a   Shanmugam, Elangovan ^a   Dhandapani, V E ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Endothelial microparticles; GRACE score; Myocardial infarction; Platelet microparticles

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENSINI SCORE; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PLATELET MICROPARTICLE; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84949456295     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/14493.6920     Document Type: Article

References (22)

1. WHO | The top 10 causes of death [Internet]. WHO. [cited 2015 Jul 14]. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/
2. Gupta S, Bhise M, Gaurav K, Gudapati R. Emerging risk factors for cardiovascular diseases: Indian context. Indian J Endocrinol Metab. 2013;17(5):806.
3. Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart Br Card Soc. 2008;94(1):16–26.
4. WHO | The Atlas of Heart Disease and Stroke [Internet]. WHO. [cited 2014 Oct 30]. Available from: http://www.who.int/cardiovascular_diseases/resources/atlas/en/
5. Heart attack: MedlinePlus Medical Encyclopedia [Internet]. [cited 2014 Dec 11]. Available from: http://www.nlm.nih.gov/medlineplus/ency/article/000195.htm
6. Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens. 2012;6(2):85–99.
7. Fan Y, Wang L, Li Y, Yin Z, Xu Z, Wang C. Quantification of endothelial microparticles on modified cytometric bead assay and prognosis in chest pain patients. Circ J. 2014;206–14.
8. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000;101(8):841–43.
9. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32(16):2034–41.
10. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol. 2009;54(7):601–08.
11. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007;21(3):157–71.
12. Van der Zee PM, Biró E, Ko Y, de Winter RJ, Hack CE, Sturk A, et al. P-selectin-and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem. 2006;52(4):657–64.
13. Biasucci LM, Porto I, Di Vito L, De Maria GL, Leone AM, Tinelli G, et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J Off J Jpn Circ Soc. 2012;76(9):2174–82.
14. Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR, et al. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res. 2006;19(2):161–66.
15. Vlietstra RE, Kronmal RA, Frye RL, Seth AK, Tristani FE, Killip T. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arterioscler Thromb Vasc Biol. 1982;2(3):208–15.
16. GRACE ACS Risk Model [Internet]. [cited 2014 Dec 12]. Available from http://www.outcomes-umassmed.org/grace/acs_risk/acs_risk_content.html
17. TIMI Risk Score for STEMI [Internet]. MDCalc. [cited 2014 Dec 11]. Available from: http://www.mdcalc.com/timi-risk-score-for-stemi/
18. TIMI Risk Score for UA/NSTEMI [Internet]. MDCalc. [cited 2014 Dec 11]. Available from: http://www.mdcalc.com/timi-risk-score-for-uanstemi/
19. Cui Y, Zheng L, Jiang M, Jia R, Zhang X, Quan Q, et al. Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Mol Biol Rep. 2013;40(11):6437–42.
20. Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-Derived Microparticles in the Pathogenesis of Cardiovascular Disease Friend or Foe? Arterioscler Thromb Vasc Biol. 2011;31(1):4–9.
21. Kuliczkowski W, Derzhko R, Prajs I, Podolak-Dawidziak M, Serebruany VL. Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions. Am J Ther. 2012;19(1):44–50.
22. Bal L, Ederhy S, Di Angelantonio E, Toti F, Zobairi F, Dufaitre G, et al. Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. Arch Cardiovasc Dis. 2010;103(6-7):394–403.